Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.
Cannabix Technologies Inc. (OTC: BLOZF) appears in its public news releases as a developer of marijuana and alcohol breath testing devices for workplaces, law enforcement and other safety-focused environments. The BLOZF news feed on Stock Titan aggregates these disclosures, giving investors and observers a single place to review the company’s reported milestones and product updates.
Company news frequently highlights progress on the Marijuana Breath Test (MBT)
Another recurring topic in Cannabix news is the BreathLogix autonomous alcohol screening platform. Announcements describe sales agreements with customers in sectors such as maritime shipping and oil and gas transportation, integration of BreathLogix with the cloud-based BreathLogix Connect portal, and features such as pre-access alcohol testing, real-time reporting and identity confirmation.
Readers of the BLOZF news page can review updates on regulatory milestones, such as FCC and Canadian emissions testing for the BCU and NHTSA Conforming Products List status for BreathLogix Workplace Series devices, as well as patent developments like the grant of a U.S. patent for contact-free breath analysis. For those tracking Cannabix’s progress in breath-based cannabis and alcohol detection technologies, this news stream offers a consolidated view of the company’s self-reported activities and partnerships over time.
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) has initiated advanced discussions with Smartox of Irving, Texas for potential sales distribution of its Breath Logix Alcohol screening device. The company has shipped the device for evaluation, preliminary marketing, and business development purposes. Cannabix is rapidly advancing its Breath Logix alcohol screening devices with certification, manufacturing, regulatory, and distribution relationships.
The Breath Logix device offers a fast, accurate, and autonomous alcohol screening process for workplace testing. It features a unique pre-calibrated, replaceable alcohol sensor cartridge, eliminating costly calibrations. The device integrates with third-party access control and biometric systems, potentially expanding the reach of alcohol device distributors worldwide.
Cannabix Technologies and Omega Laboratories have reported positive early results from testing their marijuana breathalyzer technology. Omega has initiated pre-validation work to establish detection limits for delta-9 THC, the primary psychoactive component of cannabis. Omega scientists have successfully quantified delta-9 THC in low picogram ranges using Cannabix's Breath Collection Unit (BCU). The partnership aims to advance the development and commercialization of this technology, with Omega providing extensive expertise in forensic drug testing. The collaboration includes hardware refinement, marketing, and preparation for multiple validation studies.
Cannabix Technologies and Omega Laboratories have entered a strategic partnership to commercialize Cannabix's marijuana breathalyzer technology. The agreement, effective from May 15, 2024, involves research and development, validation, and commercialization phases. Omega will be the exclusive laboratory in North America for analyzing Cannabix's delta9 THC breathalyzer samples for five years. Omega will receive 1,000,000 common shares and up to 11,000,000 special warrants of Cannabix upon achieving specific milestones. The partnership aims to enhance drug detection technology and expand its market reach in North America.
Cannabix Technologies Inc. has launched its new compact Breath Logix Workplace Series alcohol breath detection device designed for indoor facilities and offices. The company is in discussions with Run Rite Electronics Pty in South Africa for potential sales distribution. The device offers pre-access alcohol testing, random testing, start-of-shift testing, pre-employment testing, return-to-work testing, and post-incident testing. It automatically checks user sobriety, records identity, delivers Blood Alcohol Content (BAC) levels, sends real-time alerts, and logs user BAC for incident reporting. The device aims to promote organizational safety and reduce accidents linked to alcohol consumption.
Cannabix Technologies Inc. is collaborating with Breathalyser Sales & Service Pty in Australia to distribute its new Breath Logix Alcohol screening device. This device offers features like pre-calibrated cartridge technology, automatic BAC level detection, and real-time alerts for users in various sectors. Cannabix aims to provide an innovative solution for alcohol screening in workplaces and other settings.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.